Administering EX once- or twice-daily bolus s.c. injections, Egan et al[37] conducted a study taking 10 T2DM patients (insulin naïve), where the drug improved HbA(1)c (P<0.009) after one month of treatment. Here, INS is linked to type 2 diabetes mellitus.